| Code | 1235A | ||||||||||
| MA number | 27/0260/12-S | ||||||||||
| Product Form: | tbl plg 56x4 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 15.05.2012 |
| SPC: |
SPC_Raponer_tbl plg_01_2024.pdf
|
| PIL: |
PIL_Raponer_tbl plg_01_2024.pdf
|
| Safety feature | Yes |
| Data update: | 28.02.2018 |
